American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 412-420 , September 2007

Kidney Function and Aortic Valve and Mitral Annular Calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)

  • Joachim H. Ix, MD, MAS

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA
    • Department of Nephrology, University of California, San Francisco, CA
    • Corresponding Author InformationAddress correspondence to Joachim H. Ix, MD, Division of Nephrology, Department of Medicine, Box 0532, HSE 672, University of California, San Francisco, San Francisco, CA 94143-0532.
    • ,
  • Michael G. Shlipak, MD, MPH

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA
    • Department of Epidemiology and Biostatistics, University of California, San Francisco, CA
    • VA Medical Center, San Francisco, CA
    • ,
  • Ronit Katz, PhD

      Affiliations

    • Department of Biostatistics, Collaborative Health Studies Coordinating Center, University of Washington, Seattle, WA
    • ,
  • Matthew J. Budoff, MD

      Affiliations

    • Department of Medicine (Cardiology), Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
    • ,
  • David M. Shavelle, MD

      Affiliations

    • Department of Medicine (Cardiology), Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
    • ,
  • Jeffrey L. Probstfield, MD

      Affiliations

    • Department of Medicine (Cardiology), University of Washington, Seattle, WA.
    • ,
  • Junichiro Takasu, MD

      Affiliations

    • Department of Medicine (Cardiology), Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
    • ,
  • Robert Detrano, MD

      Affiliations

    • Department of Medicine (Cardiology), Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
    • ,
  • Kevin D. O’Brien, MD

      Affiliations

    • Department of Medicine (Cardiology), University of Washington, Seattle, WA.

Received 29 January 2007 ,Accepted 29 May 2007.

References 

  1. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet. 1987;2:875–877
  2. Raos V, Jeren-Strujic B, Antos M, Horvatin-Godler S. Frequency of mitral annular calcification in patients on hemodialysis estimated by 2-dimensional echocardiography. Acta Med Croatica. 1996;50:179–183
  3. Ribeiro S, Ramos A, Brandao A, et al. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant. 1998;13:2037–2040
  4. Varma R, Aronow WS, McClung JA, et al. Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. Am J Cardiol. 2005;95:742–743
  5. Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol. 2003;14:159–168
  6. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients (A link between end-stage renal disease and cardiovascular disease?). J Am Coll Cardiol. 2002;39:695–701
  7. Barasch E, Gottdiener JS, Marino Larsen EK, Chaves PH, Newman AB. Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study). Am J Cardiol. 2006;97:1281–1286
  8. Fox CS, Larson MG, Keyes MJ, et al. Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: The Framingham Heart Study. Kidney Int. 2004;66:2017–2021
  9. Kramer H, Toto R, Peshock R, Cooper R, Victor R. Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study. J Am Soc Nephrol. 2005;16:507–513
  10. Qunibi WY, Abouzahr F, Mizani MR, Nolan CR, Arya R, Hunt KJ. Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes. Kidney Int. 2005;68:271–277
  11. Fox CS, Larson MG, Vasan RS, et al. Cross-sectional association of kidney function with valvular and annular calcification: The Framingham Heart Study. J Am Soc Nephrol. 2006;17:521–527
  12. Kassirer JP. Clinical evaluation of kidney function—Glomerular function. N Engl J Med. 1971;285:385–389
  13. Seliger SL, Davis C, Stehman-Breen C. Gender and the progression of renal disease. Curr Opin Nephrol Hypertens. 2001;10:219–225
  14. Perkins BA, Nelson RG, Ostrander BE, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-year follow-up study. J Am Soc Nephrol. 2005;16:1404–1412
  15. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141:929–937
  16. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C—A new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998;101:875–881
  17. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001;37:79–83
  18. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47:312–318
  19. Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—A meta-analysis. Clin Biochem. 2007;40:383–391
  20. Mohler ER. Are atherosclerotic processes involved in aortic-valve calcification?. Lancet. 2000;356:524–525
  21. Mohler ER, Adam LP, McClelland P, Graham L, Hathaway DR. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol. 1997;17:547–552
  22. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease (Cardiovascular Health Study). J Am Coll Cardiol. 1997;29:630–634
  23. O’Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation. 1995;92:2163–2168
  24. O’Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation. 2002;106:2224–2230
  25. Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: Objectives and design. Am J Epidemiol. 2002;156:871–881
  26. Fossati P, Prencipe L, Berti G. Enzymic creatinine assay: A new colorimetric method based on hydrogen peroxide measurement. Clin Chem. 1983;29:1494–1496
  27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  28. Kramer H, Jacobs DR, Bild D, et al. Urine albumin excretion and subclinical cardiovascular disease (The Multi-Ethnic Study of Atherosclerosis). Hypertension. 2005;46:38–43
  29. Toto RD. Microalbuminuria: Definition, detection, and clinical significance. J Clin Hypertens (Greenwich). 2004;6:2–7
  30. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999;59:1–8
  31. Budoff MJ, Takasu J, Katz R, et al. Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the Multi-Ethnic Study of Atherosclerosis. Acad Radiol. 2006;13:166–172
  32. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: Standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology. 2005;234:35–43
  33. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832
  34. Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russo DJ, Raggi P. Coronary artery disease: Improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology. 1998;208:807–814
  35. Katz R, Wong ND, Kronmal R, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation. 2006;113:2113–2119
  36. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  37. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26(suppl 1):S5–S20
  38. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  39. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005;111:1313-1220
  40. Fajtova VT, Sayegh MH, Hickey N, Aliabadi P, Lazarus JM, LeBoff MS. Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int. 1995;57:329–335
  41. Martinez I, Saracho R, Montenegro J, Llach F. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis. 1997;29:496–502
  42. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  43. Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care. 2001;24:335–338
  44. US Renal Data System. USRDS 2002 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2002;
  45. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245–252
  46. Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68:1815–1824
  47. Raggi P, Bommer J, Chertow GM. Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. J Heart Valve Dis. 2004;13:134–141
  48. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004;44:1024–1030

 Originally published online as doi:10.1053/j.ajkd.2007.05.020 on July 24, 2007.

PII: S0272-6386(07)00892-X

doi: 10.1053/j.ajkd.2007.05.020

American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 412-420 , September 2007

Article Tools

* Image Usage & Resolution